Pages that link to "Q33644875"

The following pages link to YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway (Q33644875):

Displaying 50 items.

• PTPN14 is required for the density-dependent control of YAP1 (Q24297998) (← links)
• Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover (Q24303432) (← links)
• Mammalian MST2 kinase and human Salvador activate and reduce estrogen receptor alpha in the absence of ligand (Q24308077) (← links)
• PTPN14 interacts with and negatively regulates the oncogenic function of YAP (Q24316475) (← links)
• Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein (Q24323326) (← links)
• The Hippo Signaling Pathway in Development and Cancer (Q24603986) (← links)
• YAP-Mediated Mechanotransduction in Skeletal Muscle (Q26766774) (← links)
• Emerging role of Hippo pathway in gastric and other gastrointestinal cancers (Q26774473) (← links)
• The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis (Q26775126) (← links)
• At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone (Q26866067) (← links)
• The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment (Q27025661) (← links)
• Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy (Q28078129) (← links)
• Emerging Role of the Hippo Signaling Pathway in Position Sensing and Lineage Specification in Mammalian Preimplantation Embryos (Q28083971) (← links)
• YAP and TAZ: a nexus for Hippo signaling and beyond (Q28085636) (← links)
• YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells (Q28250934) (← links)
• The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version (Q28281214) (← links)
• The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα (Q28596581) (← links)
• Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit (Q28742574) (← links)
• Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway (Q30278951) (← links)
• The Hippo-YAP signaling pathway and contact inhibition of growth (Q30408095) (← links)
• Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1 (Q30417692) (← links)
• Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma (Q33594370) (← links)
• Molecular evolution of the Yap/Yorkie proto-oncogene and elucidation of its core transcriptional program (Q33654331) (← links)
• The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells (Q33676720) (← links)
• Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer (Q33817465) (← links)
• KRAS and YAP1 converge to regulate EMT and tumor survival (Q33946244) (← links)
• Yki/YAP, Sd/TEAD and Hth/MEIS control tissue specification in the Drosophila eye disc epithelium (Q33979785) (← links)
• PP1A-mediated dephosphorylation positively regulates YAP2 activity (Q34016621) (← links)
• Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis (Q34077954) (← links)
• Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor (Q34207272) (← links)
• The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis (Q34246027) (← links)
• Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene (Q34267908) (← links)
• Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. (Q34324645) (← links)
• Willin, an upstream component of the hippo signaling pathway, orchestrates mammalian peripheral nerve fibroblasts (Q34339790) (← links)
• The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration (Q34342516) (← links)
• Principles of liver regeneration and growth homeostasis (Q34347580) (← links)
• Merlin is a negative regulator of human melanoma growth (Q34389516) (← links)
• Hippo signaling regulatesDrosophilaintestine stem cell proliferation through multiple pathways (Q34396983) (← links)
• YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues (Q34463427) (← links)
• YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors (Q34463878) (← links)
• A gp130-Src-YAP module links inflammation to epithelial regeneration (Q34465259) (← links)
• Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein (Q34469155) (← links)
• The Hippo pathway controls border cell migration through distinct mechanisms in outer border cells and polar cells of the Drosophila ovary (Q34471565) (← links)
• Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover (Q34535458) (← links)
• TAZ expression as a prognostic indicator in colorectal cancer (Q34571020) (← links)
• The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation (Q34979150) (← links)
• Prenatal exposure to dietary fat induces changes in the transcriptional factors, TEF and YAP, which may stimulate differentiation of peptide neurons in rat hypothalamus (Q35023315) (← links)
• Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules (Q35090002) (← links)
• The Hippo pathway regulates homeostatic growth of stem cell niche precursors in the Drosophila ovary (Q35099085) (← links)
• Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis (Q35157451) (← links)